Peter Dogterom

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 111 citations · Full text

Development of a simple incubation system for metabolism studies with precision-cut liver slices.

Peter Dogterom · Drug Metabolism and Disposition · 1993 · 101 citations

Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial

Kari R. Nations, Peter Dogterom, Roberta Bursi et al. · Journal of Psychopharmacology · 2012 · 70 citations

Application of Absorption Modeling to Predict Bioequivalence Outcome of Two Batches of Etoricoxib Tablets

Amitava Mitra, Filippos Kesisoglou, Peter Dogterom · AAPS PharmSciTech · 2014 · 69 citations · Full text

Etoricoxib Tablets, Bioequivalence, Medicine +12

Effect of a High-Fat Meal on the Pharmacokinetics of 300-Milligram Posaconazole in a Solid Oral Tablet Formulation

Wendy M. Kersemaekers, Peter Dogterom, Jialin Xu et al. · Antimicrobial Agents and Chemotherapy · 2015 · 61 citations · Full text

Nutrition, 300-Milligram Posaconazole, Oral Suspension +18